Lung perfusion with protective solution relieves lung injury in corrections of Tetralogy of Fallot

Bo Wei1, Yinglong Liu, Qiang Wang

  • 1Department of Surgery, FuWai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. wi1bo1208@hotmail.com

Insights

Pulmonary perfusion with hypothermic solution improved lung function and reduced injury markers in children undergoing Tetralogy of Fallot repair. This method offers a protective effect against lung damage during cardiopulmonary bypass.

Area of Science:

  • Cardiology
  • Pediatric Surgery
  • Pulmonology

Background:

  • Tetralogy of Fallot repair often involves cardiopulmonary bypass (CPB), which can lead to lung injury.
  • Lung injury post-CPB can manifest as impaired oxygenation and prolonged ventilation.
  • Evaluating protective strategies for lung function during CPB is crucial in pediatric cardiac surgery.

Purpose of the Study:

  • To assess the protective impact of pulmonary perfusion with a hypothermic solution on lung function following CPB in Tetralogy of Fallot correction.
  • To investigate the underlying mechanisms of CPB-induced lung injury and the potential mitigation by the protective solution.

Main Methods:

  • A randomized controlled trial involving 64 children with Tetralogy of Fallot undergoing CPB.
  • The protective group received pulmonary perfusion with hypothermic solution, while the control group did not.
  • Monitoring of hemodynamic and lung function parameters, measurement of inflammatory markers (TNF-α, IL-6, IL-8), endothelial markers (vWF, endothelin), and oxidative stress markers (MDA).
  • Histopathological examination of lung biopsy specimens.

Main Results:

  • The protective group demonstrated significantly better oxygenation (oxygen index, A-a O2 gradient) and reduced mechanical ventilation time and ICU stay.
  • Lower levels of plasma malondialdehyde and tumor necrosis factor-alpha were observed in the protective group.
  • Reduced levels of interleukin-6 and -8 in bronchoalveolar lavage fluid were noted in the protective group.
  • Histopathology revealed less lung injury, including edema and leukocyte accumulation, in the protective group compared to the control group.

Conclusions:

  • Pulmonary perfusion with hypothermic protective solution effectively mitigates lung injury associated with cardiopulmonary bypass in Tetralogy of Fallot repair.
  • The protective mechanism likely involves the inhibition of lung vascular endothelial cell injury.
  • This strategy offers a promising approach to improve outcomes in pediatric cardiac surgery patients.
Abstract